3 questions to learn if your baby's gut is healthy.
Antibiotic resistance is a global health epidemic
Globally, 40% of newborn infections are resistant to standard antibiotic treatment indicating a reservoir of antibiotic-resistant genes in this population.55 These babies can become vectors of antibiotic-resistant genes, spreading bacteria to family members and playmates. We are looking at a global epidemic. It is time to take preventative action for your patients now.
What can be done to address the antibiotic-resistant crisis? Given your infant patients' immune system is rapidly developing in their first six months of life, it is important to take swift, effective steps to reduce antibiotic resistance in the microbiome. The first step is Evivo. Evivo® (activated B. infantis EVC001, Actibif®) in combination with human milk, is the first and only clinically-proven infant probiotic to fight against antibiotic resistance.
In a recently published clinical study, infants fed Evivo had lower total levels of ARGs in the gut microbiome.58 Evivo works with breast milk to suppress the growth of potentially pathogenic bacteria that harbor the genes responsible for antibiotic resistance.
9 out of 10 babies today lack the key beneficial bacteria B. infantis EVCOO1. Evivo is the only clinically-proven probiotic that restores B infantis to the infant gut microbiome and reduces antibiotic-resistant genes from the start.
Fight antibiotic resistance in your patients with the first and only clinically proven infant probiotic. Evivo.
Request patient samples for your practice
Get the latest updates.
Notify me when available
There are a fast-growing number of bacteria in our environment that have figured out how to resist the antibiotics we depend on to treat infections. In fact, antibiotic resistance is now considered a global health threat, and this problem starts the day your baby is born. A new study shows that even healthy, breastfed babies were found to have high levels of bacteria in their gut that were capable of antibiotic resistance in the first week of life. However, the study showed that when babies were fed the specific strain of probiotic bacteria found in Evivo (activated B. infantis EVC001), the level of potentially antibiotic-resistant bacteria was reduced by 90% compared to babies who didn’t receive Evivo. This safe and effective approach to reducing potentially dangerous bacteria in baby’s gut microbiome is a huge step forward in the fight against antibiotic resistance.
View Journal Article